Targeted Cancer Therapeutics: Biosynthetic and Energetic Pathways Characterized by Metabolomics and the Interplay with Key Cancer Regulatory Factors

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|20|15|2637-2647

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.20, Iss.15, 2014-05, pp. : 2637-2647

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The emergence of resistance to targeted cancer therapeutics

By Mellinghoff Ingo K   Sawyers Charles L  

Pharmacogenomics, Vol. 3, Iss. 5, 2002-09 ,pp. : 603-623

Future Medicine

Access to resources Recommend Favorite

Bcl-2-targeted cancer therapeutics

By Khorchid Amani   Beauparlant Pierre  

Expert Opinion on Therapeutic Patents, Vol. 14, Iss. 6, 2004-06 ,pp. : 805-818

Informa Healthcare

Access to resources Recommend Favorite

Editorial (Hot Topic: Development of New Molecular Agents Targeting Key Signalling Pathways Activated by Growth Factors in Human Cancer)

By  

Current Pharmaceutical Design, Vol. 19, Iss. 5, 2013-02 ,pp. : 807-807

Bentham Science Publishers

Access to resources Recommend Favorite

Peptide-directed HPMA copolymer-doxorubicin conjugates as targeted therapeutics for colorectal cancer

By Kopansky Eva   Shamay Yosi   David Ayelet  

Journal of Drug Targeting, Vol. 19, Iss. 10, 2011-12 ,pp. : 933-943

Informa Healthcare

Access to resources Recommend Favorite

HGF/c-MET Targeted Therapeutics: Novel Strategies for Cancer Medicine

By  

Current Drug Targets, Vol. 12, Iss. 14, 2011-12 ,pp. : 2045-2058

Bentham Science Publishers

Access to resources Recommend Favorite